Sodium Valproate

(asked on 11th June 2015) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what information he holds on what knowledge his Department had of the emergence of risks associated with sodium valproate within the first five years following first prescription of that drug.


Answered by
George Freeman Portrait
George Freeman
This question was answered on 19th June 2015

Sodium valproate was licensed in the United Kingdom in 1972 as a treatment for epilepsy and was marketed in 1974 for general prescription. The risks known to be associated with sodium valproate at that time were described in the data sheet first published in 1975 in the Association of British Pharmaceutical Industry (ABPI) Data Sheet Compendium. A copy is attached.

The safety of sodium valproate was monitored after licensing using data from the Yellow Card Scheme, which was set up in 1964 to collect reports of suspected adverse reactions to medicines. The data sheet published in the 1980-81 ABPI Data Sheet Compendium reflects the safety profile of sodium valproate following five years of availability on general prescription. A copy is attached.

This content was generated for your convenience by Parallel Parliament and does not form part of the official record.
Recent Documents related to Sodium Valproate

1. Valproate and Fetal Anti-Convulsant Syndrome
17/10/2017 - Parliamentary Research

Found: PACK Number CDP 2017/0186, 17 October 2017 Valproate and Fetal Anti-Convulsant Syndrome Dr Sarah Barber

2. Drug Safety Update: monthly PDF newsletter
21/11/2019 - Medicines and Healthcare products Regulatory Agency (MHRA)
- View source

Found: 4 Drug Safety Update Latest advice for medicines users The monthly newsletter from the Medicines

3. Northern Ireland Sodium Valproate Monitoring Report, July to December 2020
18/02/2021 - HSC Business Services Organisation (Northern Ireland) (HSC)
- View source

Found: Northern_Ireland All Sodium Valproate Patients in Northern Ireland by Age Group Verifiable Patients

4. Valproate banned without the pregnancy prevention programme
24/04/2018 - Medicines and Healthcare products Regulatory Agency (MHRA)
- View source

Found: Valproate banned without the pregnancy prevention programme - GOV.UK

5. Valproate medicines: are you acting in compliance with the pregnancy prevention measures?
18/12/2018 - Medicines and Healthcare products Regulatory Agency (MHRA)
- View source

Found: Valproate medicines: are you acting in compliance with the pregnancy

Latest Documents
Recent Speeches related to Sodium Valproate

1. Valproate Pregnancy Prevention Programme
21/03/2019 - Commons Chamber

1: travel to and from London to demand action from drug companies, politicians and civil servants, and they - Speech Link

2. Valproate and Foetal Anticonvulsant Syndrome
19/10/2017 - Commons Chamber

1: women of the dangers of taking the epilepsy drug sodium valproate during pregnancy, resulting in thousands - Speech Link
2: women of the dangers of taking the epilepsy drug sodium valproate during pregnancy, resulting in thousands - Speech Link

3. Independent Medicines and Medical Devices Safety Review
08/07/2021 - Commons Chamber

1: Independent Medicines and Medical Devices Safety Review, First Do No Harm; further notes the Government’s failure - Speech Link
2: Independent Medicines and Medical Devices Safety Review, First Do No Harm; further notes the Government’s failure - Speech Link
3: repeated time and time again when it comes to women’s health. Enough is enough. Today’s motion calls on the - Speech Link

4. Independent Medicines and Medical Devices Safety Review
09/07/2020 - Commons Chamber

1: used by the NHS. It focused on three areas. The first is Primodos, a hormone-based pregnancy test that - Speech Link
2: to highlight the harm caused by Primodos, sodium valproate and pelvic mesh have been called every name - Speech Link

5. Medicines and Medical Devices Safety Review
21/02/2018 - Commons Chamber

1: technology summit, which is being held for the first time outside the United States here in London. As - Speech Link

Latest Speeches
Recent Questions related to Sodium Valproate
1. Prescription Drugs: Sodium Valproate
asked by: Cat Smith
14/03/2018
... which NHS prescription drugs contain (a) Valproate and (b) Sodium Valproate or their derivatives; and what warnings are given to patients of the associated risks to pregnant women.

2. Department of Health and Social Care: Information
asked by: Matthew Offord
15/07/2021
... what mechanisms are in place to audit information provided to his Department by (a) regulatory bodies and (b) non-departmental public bodies.

3. Department of Health: Information Officers
asked by: Justin Madders
07/02/2017
... how many (a) of his Department's and (b) NHS England staff are employed in media relations and communications roles; and how much was spent on the salaries of those staff members in each of the last three years.

4. Department of Health: Disclosure of Information
asked by: Jon Trickett
13/09/2017
... what steps he is taking to promote whistleblowing in his Department and agencies.

5. Department of Health: Disclosure of Information
asked by: Justin Madders
12/07/2017
... how many protected disclosures were made by staff in his Department in each of the last three years for which figures are available; how many such disclosures were found to be valid; how many staff alleged detriment as a result of making such a disclosure; and how many staff who (a) made such a disclosure and (b) alleged detriment as a result of a disclosure subsequently left the employment of the Department.

Latest Questions